April 13, 2025 07:47 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
15 flights diverted, many delayed as dust storm hits Delhi, Haryana | AIADMK, BJP join hands again to contest Tamil Nadu elections under Edappadi K Palaniswami | PM Modi inaugurates Rs. 3,880-cr projects in Varanasi on 50th visit to his Lok Sabha constituency | Bengal job losers camp outside SSC office in Kolkata, demand mirror copies of genuine candidate list | Mumbai terror attack accused Tahawwur Rana sent to 18-day NIA custody | Donald Trump's latest tariff hike on Beijing brings additional rate on some Chinese goods to 145 pct: White House | Pakistan distances itself from 26/11 terror accused Tahawwur Rana, says he is 'Canadian national' | Tahawwur Rana’s extradition proof of Modi govt's diplomatic strength: Amit Shah | Adult unmarried parents can live together without marriage: Allahabad High Court | Bengal job losers hold massive rally in Kolkata protesting over police assault
Fighting COVID-19: New Zealand secures another medicine

Fighting COVID-19: New Zealand secures another medicine

Nov 05, 2021, at 09:58 pm

Wellington/UNI/Xinhua: The addition of another drug to the suite of COVID-19 medicines available in New Zealand is good news for patients and for the health system, Health Minister Andrew Little said on Friday.

Dr Reddy Labs enters in voluntary licensing agreement with Eli Lilly to access it’s Covid treatment in India

Dr Reddy Labs enters in voluntary licensing agreement with Eli Lilly to access it’s Covid treatment in India

May 12, 2021, at 09:48 pm

Hyderabad/UNI: Dr Reddy’s Laboratories on Wednesday announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company (“Lilly”) for the manufacture and commercialization of the drug Baricitinib in India.

Close menu